Ims Information Solutions Medical Research Limited

Ims Information Solutions Medical Research Limited is a company in London, United Kingdom that has taken part in 2 EU-funded projects since 2011, receiving €320k in EU funding.

EU funding received€320k
EU projects2
As coordinator0
Running now0
First EU project2011
Latest project2018
CountryUnited Kingdom
EU registration (PIC)972926491
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Ims Information Solutions Medical Research Limited's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€320k · 1 project
  • Horizon 2020€0 · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • PIONEERPartner

    Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

  • ASTRO-LABPartner

    ASSESSMENT OF THE SAFETY OF LABAS IN ASTHMA IN ROUTINE CARE BY COMBINING HEALTH-CARE DATABASES AND DIRECT PATIENT FOLLOW-UP

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €320ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • asthma
  • databases
  • oncology
  • public health

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime